Wang, Chen <br/><br/>
Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study.  [electronic resource] 

 -  International journal of chronic obstructive pulmonary disease  2015 
 - 57-68 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1178-2005 
<br/><br/><label>Standard No.: </label>10.2147/COPD.S72650  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Asian People<br/>Bronchodilator Agents--administration & dosage<br/>China--epidemiology<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Dyspnea--diagnosis<br/>Female<br/>Forced Expiratory Volume<br/>Glycopyrrolate--administration & dosage<br/>Health Status<br/>Humans<br/>India--epidemiology<br/>Lung--drug effects<br/>Male<br/>Middle Aged<br/>Muscarinic Antagonists--administration & dosage<br/>Philippines--epidemiology<br/>Pulmonary Disease, Chronic Obstructive--diagnosis<br/>Recovery of Function<br/>Republic of Korea--epidemiology<br/>Severity of Illness Index<br/>Spirometry<br/>Surveys and Questionnaires<br/>Time Factors<br/>Treatment Outcome<br/>Vital Capacity